These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 18549449)

  • 1. Model for the end-stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation.
    Brandão A; Fuchs SC; Gleisner AL; Marroni C; Zanotelli ML; Cantisani G
    Clin Transplant; 2008; 22(5):651-6. PubMed ID: 18549449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model for end-stage liver disease (MELD) and allocation of donor livers.
    Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
    Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list.
    Castro RS; Deisanti D; Seva-Pereira T; Almeida JR; Yamanaka A; Boin IF; Soares EC
    Transplant Proc; 2010 Mar; 42(2):412-6. PubMed ID: 20304153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.
    Gheorghe L; Popescu I; Iacob R; Iacob S; Gheorghe C
    Transpl Int; 2005 May; 18(5):572-6. PubMed ID: 15819806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
    Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
    Ben-Haim M; Carmiel M; Katz P; Shabtai E; Oren R; Nakache R
    Isr Med Assoc J; 2006 Sep; 8(9):605-9. PubMed ID: 17058408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of MELD and Child-Turcotte-Pugh scores and the Canadian waitlisting algorithm in predicting short-term survival after liver transplant.
    Bazarah SM; Peltekian KM; McAlister VC; Bitter-Suermann H; MacDonald AS
    Clin Invest Med; 2004 Aug; 27(4):162-7. PubMed ID: 15453152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum sodium predicts mortality in patients listed for liver transplantation.
    Biggins SW; Rodriguez HJ; Bacchetti P; Bass NM; Roberts JP; Terrault NA
    Hepatology; 2005 Jan; 41(1):32-9. PubMed ID: 15690479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.
    Chan HL; Chim AM; Lau JT; Hui AY; Wong VW; Sung JJ
    Am J Gastroenterol; 2006 Jul; 101(7):1516-23. PubMed ID: 16863555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?
    Kanwal F; Hays RD; Kilbourne AM; Dulai GS; Gralnek IM
    Am J Gastroenterol; 2004 Sep; 99(9):1726-32. PubMed ID: 15330910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of the MELD score as a predictor of death on the waiting list for liver transplantation.
    Gheorghe L; Iacob S; Iacob R; Gheorghe C; Popescu I
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):267-72. PubMed ID: 17925920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.
    Said A; Williams J; Holden J; Remington P; Gangnon R; Musat A; Lucey MR
    J Hepatol; 2004 Jun; 40(6):897-903. PubMed ID: 15158328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.